Introduction
Accurate determination of plasma protein binding (PPB) has been a challenge for many years as a decent fraction of compounds from different classes such as:
- Peptides and peptidometics
- Oligonucleic acids
- Small molecules
Accurate determination of plasma protein binding (PPB) has been a challenge for many years as a decent fraction of compounds from different classes such as:
- Peptides and peptidometics
- Oligonucleic acids
- Small molecules
Blog Posts
The 20 latest Blog Posts
- ARTBIO to Enter into Licensing and Research Partnership with 3B Pharmaceuticals to Advance a First-in-Class Alpha Radioligand Therapy for Solid Tumors
- 3B Pharmaceuticals Announces Option and Asset Purchase Agreement with Novartis for PSMA Radioligand Therapy Program
- RefleXion Acquires Global Rights to Radiopharmaceutical Molecule from 3B Pharmaceuticals to Treat High Unmet Need Cancers Including Brain, Pancreatic and Liver
- 3B Pharmaceuticals enters into a Global Exclusive Licensing Agreement for its FAP-Targeting Peptide Technology
- 3BP company statement re recent events involving Clovis Oncology and FAP-2286
- 3B Pharmaceuticals hosts industry symposium on radiopharmaceutical innovation alliances and supports the 6th Theranostic World Congress
- Debiopharm expands its radiopharmaceutical footprint with an exclusive in-licensing agreement of 3B Pharmaceutical’s targeted CAIX radiotherapy
- Clovis Oncology Acquires Rights to FAP-Targeted Radiopharmaceutical Program from 3B Pharmaceuticals
- Boehringer Ingelheim and 3B Pharmaceuticals sign drug discovery collaboration
- Ipsen and 3BP announce First Patient Dosed in Phase I/II study for first-in-class radionuclide (IPN01087)
- 3B Pharmaceuticals and Sovicell introduce a novel service offering for plasma protein binding analysis
- KNAUER and 3B Pharmaceuticals showcase novel affinity purification process for camelid antibodies
- Ipsen enters into a licensing agreement with 3B Pharmaceuticals to develop novel radiopharmaceuticals in oncology
Pages
Available Pages
- Data Privacy Statement for Job Applications
- Datenschutzerklärung
- Homepage
- Notice to job applicants regarding an ongoing recruitment scam in the U.S.
- Request Information
- Testseite blau
- EScalate Assay
- Imaging
- Pipeline
- Pipeline Chart
- PurAffin Chromatography
- Radiopharmaceuticals
- Targeted Radiotherapy
- Team
- 3BP Assets
- About Nuclear Medicine
- Contact
- Isotopes
- Publications
- Technology
- Therapy
- About us
- Bioseparation & Bioprocess
- Clinical Trials
- Directions
- Request information
- Technology
- Theragnostics
- Indications
- Publications
- Careers
- News
- Partnering
- Imprint
- Data privacy statement
Categories
Monthly